These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 14752076)

  • 21. E2F1/TS Immunophenotype and Survival of Patients with Colorectal Cancer Treated with 5FU-Based Adjuvant Therapy.
    Sulzyc-Bielicka V; Domagala P; Bielicki D; Safranow K; Rogowski W; Domagala W
    Pathol Oncol Res; 2016 Jul; 22(3):601-8. PubMed ID: 26831819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic value of thymidylate synthase, topoisomerase-1 and Ki-67 in advanced colorectal cancer patients on irinotecan and fluorouracil treatment].
    Xu JM; Zhu BD; Mangia A; Simone G; Montemurro S; Giuliani F; Maiello E; Colucci G; Paradiso A
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):312-5. PubMed ID: 15996331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
    Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
    Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymidylate synthase (TS) protein expression as a prognostic factor in advanced colorectal cancer: a comparison with TS mRNA expression.
    Nakagawa T; Shimada M; Kurita N; Iwata T; Nishioka M; Yoshikawa K; Higashijima J; Utsunomiya T
    Hepatogastroenterology; 2012 Jun; 59(116):1059-62. PubMed ID: 22580655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer.
    Johnston PG; Fisher ER; Rockette HE; Fisher B; Wolmark N; Drake JC; Chabner BA; Allegra CJ
    J Clin Oncol; 1994 Dec; 12(12):2640-7. PubMed ID: 7989939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymidylate synthase level and DNA-ploidy pattern as possible prognostic factors in human colorectal cancer: a preliminary study.
    Sanguedolce R; Brumarescu I; Dardanoni G; Grassadonia A; Vultaggio G; Rausa L
    Anticancer Res; 1995; 15(3):901-6. PubMed ID: 7645979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients.
    Paradiso A; Xu J; Mangia A; Chiriatti A; Simone G; Zito A; Montemurro S; Giuliani F; Maiello E; Colucci G
    Int J Cancer; 2004 Aug; 111(2):252-8. PubMed ID: 15197779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy.
    Shirota Y; Stoehlmacher J; Brabender J; Xiong YP; Uetake H; Danenberg KD; Groshen S; Tsao-Wei DD; Danenberg PV; Lenz HJ
    J Clin Oncol; 2001 Dec; 19(23):4298-304. PubMed ID: 11731512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.
    Mauritz R; Giovannetti E; Beumer IJ; Smid K; Van Groeningen CJ; Pinedo HM; Peters GJ
    Clin Colorectal Cancer; 2009 Jul; 8(3):146-54. PubMed ID: 19632929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymidylate synthase expression and outcome of patients receiving pemetrexed for advanced nonsquamous non-small-cell lung cancer in a prospective blinded assessment phase II clinical trial.
    Nicolson MC; Fennell DA; Ferry D; O'Byrne K; Shah R; Potter V; Skailes G; Upadhyay S; Taylor P; André V; Nguyen TS; Myrand SP; Visseren-Grul C; Das M; Kerr KM
    J Thorac Oncol; 2013 Jul; 8(7):930-9. PubMed ID: 23722170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of the thymidylate biosynthetic enzymes in human colorectal tumors.
    Kralovánszky J; Köves I; Orosz Z; Katona C; Tóth K; Rahóty P; Czeglédi F; Kovács T; Budai B; Hullán L; Jeney A
    Oncology; 2002; 62(2):167-74. PubMed ID: 11914603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil.
    Negri FV; Azzoni C; Bottarelli L; Campanini N; Mandolesi A; Wotherspoon A; Cunningham D; Scartozzi M; Cascinu S; Tinelli C; Silini EM; Ardizzoni A
    Anticancer Res; 2013 Oct; 33(10):4611-7. PubMed ID: 24123038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marked variation of thymidylate synthase and folylpolyglutamate synthetase gene expression in human colorectal tumors.
    Mini E; Biondi C; Morganti M; Napoli C; Mazzoni P; Cianchi F; Tonelli F; Cortesini C; Capaccioli S; Ficari F; Quattrone A; Rossi S; Mazzei T
    Oncol Res; 1999; 11(9):437-45. PubMed ID: 10821538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymidylate synthase expression and prognosis of patients with gastrointestinal cancers receiving adjuvant chemotherapy: a review.
    Formentini A; Henne-Bruns D; Kornmann M
    Langenbecks Arch Surg; 2004 Oct; 389(5):405-13. PubMed ID: 15309542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymidylate synthase and cyclin D1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?
    Formentini A; Henne-Bruns D; Kornmann M
    Hepatogastroenterology; 2012 Sep; 59(118):1859-64. PubMed ID: 22819905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A combined analysis of mismatch repair status and thymidylate synthase expression in stage II and III colon cancer.
    Öhrling K; Karlberg M; Edler D; Hallström M; Ragnhammar P
    Clin Colorectal Cancer; 2013 Jun; 12(2):128-35. PubMed ID: 23276521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of thymidylate synthase levels in the prognosis and the treatment of patients with colorectal cancer.
    Sanguedolce R; Vultaggio G; Sanguedolce F; Modica G; Li Volsi F; Diana G; Guereio G; Bellanca L; Rausa L
    Anticancer Res; 1998; 18(3A):1515-20. PubMed ID: 9673363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical expression of thymidylate synthase as a prognostic factor and as a chemotherapeutic efficacy index in patients with colorectal carcinoma.
    Tachikawa D; Arima S; Futami K
    Anticancer Res; 2000; 20(6A):4103-7. PubMed ID: 11131679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer.
    Aguiar S; Lopes A; Soares FA; Rossi BM; Ferreira FO; Nakagawa WT; Carvalho AL; Filho WJ
    Eur J Surg Oncol; 2005 Oct; 31(8):863-8. PubMed ID: 15923105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of thymidylate synthase (TS) and its prognostic significance in patients with cutaneous angiosarcoma.
    Shimizu A; Kaira K; Okubo Y; Utsumi D; Bolag A; Yasuda M; Takahashi K; Ishikawa O
    Neoplasma; 2017; 64(6):916-921. PubMed ID: 28895418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.